This study reveals a CUL3–EHMT2–Aurora B regulatory axis that safeguards accurate chromosome segregation in PCa cells, supporting the potential therapeutic application of EHMT2 inhibitors. This evidence concerns the gene CUL3 and posterior cortical atrophy.